Johnson & Johnson has begun vaccinating adolescent participants in the ongoing Phase 2a clinical trial for its covid-19 vaccine candidate, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson.This trial is currently enrolling participants in Spain and the United Kingdom; enrolment will commence shortly in the United States, the Netherlands and Canada, with Brazil and Argentina to follow.
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.